ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 17: Congenital malformations and chromosomal abnormalitiesQ23

Q23

Non-billable

Congenital malformations of aortic and mitral valves

Chapter 17:Congenital malformations and chromosomal abnormalities

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 Q23 is a used to indicate a diagnosis of congenital malformations of aortic and mitral valves.

Key Diagnostic Point:

The ICD-10 Level 1 Category code Q23 encompasses congenital malformations of the aortic and mitral valves, which are critical components of the heart's anatomy. These malformations can lead to significant hemodynamic disturbances and may present with a range of clinical symptoms, including heart murmurs, heart failure, and cyanosis. Conditions covered under this category include aortic stenosis, mitral valve prolapse, and other structural anomalies that affect the function of these valves. Early detection and management are crucial to prevent complications such as infective endocarditis and progressive heart failure, making this category clinically significant in pediatric and adult populations alike.

  • The usage of Q23 codes is essential for accurate medical coding and billing, as it ensures proper documentation of congenital heart defects. Clinicians should be aware of the specific conditions that fall under this category to facilitate appropriate coding. Additionally, understanding the clinical implications of these malformations can aid in the development of treatment plans and monitoring strategies for affected patients. Accurate coding also plays a vital role in research and epidemiological studies related to congenital heart defects, contributing to better healthcare outcomes and resource allocation.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of conditions covered
  • Need for detailed clinical documentation
  • Potential for associated complications

Audit Risk Factors

  • Inadequate documentation of specific valve anomalies
  • Misclassification of congenital conditions
  • Failure to capture associated complications

Specialty Focus

Medical Specialties

Cardiology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Pediatrics

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The clinical and administrative impact of the Q23 code category is significant, as it plays a crucial role in tracking and managing congenital heart defects. Accurate coding can influence quality measures, such as those related to surgical outcomes and long-term patient management. Furthermore, understanding the prevalence and types of congenital valve malformations can inform population health initiatives aimed at improving early detection and treatment strategies.
From an administrative perspective, the proper use of Q23 codes can enhance data collection for research purposes, leading to better insights into the epidemiology of congenital heart defects. This, in turn, can shape healthcare policies and funding allocations to support affected populations. As healthcare trends evolve, the focus on congenital conditions and their management will likely continue to grow, highlighting the importance of accurate coding and documentation in improving patient outcomes.

ICD-9 vs ICD-10

The clinical and administrative impact of the Q23 code category is significant, as it plays a crucial role in tracking and managing congenital heart defects. Accurate coding can influence quality measures, such as those related to surgical outcomes and long-term patient management. Furthermore, understanding the prevalence and types of congenital valve malformations can inform population health initiatives aimed at improving early detection and treatment strategies. From an administrative perspective, the proper use of Q23 codes can enhance data collection for research purposes, leading to better insights into the epidemiology of congenital heart defects. This, in turn, can shape healthcare policies and funding allocations to support affected populations. As healthcare trends evolve, the focus on congenital conditions and their management will likely continue to grow, highlighting the importance of accurate coding and documentation in improving patient outcomes.

Reimbursement & Billing Impact

Reimbursement considerations may vary based on the specific malformation and the treatment provided, including surgical interventions or ongoing management of heart failure symptoms. It is essential to stay updated on payer policies regarding coverage for congenital heart defects, as these can influence billing practices and reimbursement rates.

Resources

Clinical References

  • •
    Official ICD-10 Guidelines for Q23

Coding & Billing References

  • •
    Official ICD-10 Guidelines for Q23

Frequently Asked Questions

What conditions are included in Q23?

Q23 includes congenital malformations such as aortic stenosis, mitral valve prolapse, and other structural anomalies affecting the aortic and mitral valves.

When should I use Q23 codes?

Q23 codes should be used when diagnosing congenital malformations of the aortic and mitral valves, particularly when these conditions are confirmed through imaging or clinical evaluation.

What documentation is required for Q23?

Documentation should include clinical findings, imaging results (such as echocardiograms), and any associated symptoms or complications related to the valve malformations.